Tech Company Financing Transactions

Edwards Lifesciences Funding Round

Edwards Lifesciences secured a $272.4 million venture capital round on 2/9/2017. Backers included private investors.

Transaction Overview

Announced On
2/9/2017
Transaction Type
Venture Equity
Amount
$272,371,872
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 25 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.

Company Information

Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
1 Edwards Way
Irvine, CA 92614
USA
Email Address
Overview
Committed to addressing the unmet needs of patients with structural heart disease and the critically ill.
Profile
Edwards Lifesciences LinkedIn Company Profile
Social Media
Edwards Lifesciences Company Twitter Account
Company News
Edwards Lifesciences News
Facebook
Edwards Lifesciences on Facebook
YouTube
Edwards Lifesciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Michael Mussallem
  Michael Mussallem LinkedIn Profile  Michael Mussallem Twitter Account  Michael Mussallem News  Michael Mussallem on Facebook
Chief Financial Officer
Scott Ullem
  Scott Ullem LinkedIn Profile  Scott Ullem Twitter Account  Scott Ullem News  Scott Ullem on Facebook
Chief Scientific Officer
Stanton Rowe
  Stanton Rowe LinkedIn Profile  Stanton Rowe Twitter Account  Stanton Rowe News  Stanton Rowe on Facebook
Vice President
Jean-Luc Lemercier
  Jean-Luc Lemercier LinkedIn Profile  Jean-Luc Lemercier Twitter Account  Jean-Luc Lemercier News  Jean-Luc Lemercier on Facebook
Vice President
Joseph Nuzzolese
  Joseph Nuzzolese LinkedIn Profile  Joseph Nuzzolese Twitter Account  Joseph Nuzzolese News  Joseph Nuzzolese on Facebook
Vice President
Catherine Szyman
  Catherine Szyman LinkedIn Profile  Catherine Szyman Twitter Account  Catherine Szyman News  Catherine Szyman on Facebook
Vice President
Huimin Wang
  Huimin Wang LinkedIn Profile  Huimin Wang Twitter Account  Huimin Wang News  Huimin Wang on Facebook
Vice President
Larry Wood
  Larry Wood LinkedIn Profile  Larry Wood Twitter Account  Larry Wood News  Larry Wood on Facebook
Vice President
Bernard Zovighian
  Bernard Zovighian LinkedIn Profile  Bernard Zovighian Twitter Account  Bernard Zovighian News  Bernard Zovighian on Facebook
VP - Bus. Development
Donald Bobo
  Donald Bobo LinkedIn Profile  Donald Bobo Twitter Account  Donald Bobo News  Donald Bobo on Facebook
VP - General Counsel
Aimee Weisner
  Aimee Weisner LinkedIn Profile  Aimee Weisner Twitter Account  Aimee Weisner News  Aimee Weisner on Facebook
VP - Human Resources
Christine McCauley
  Christine McCauley LinkedIn Profile  Christine McCauley Twitter Account  Christine McCauley News  Christine McCauley on Facebook
VP - Regulatory Affairs
Dirksen Lehman
  Dirksen Lehman LinkedIn Profile  Dirksen Lehman Twitter Account  Dirksen Lehman News  Dirksen Lehman on Facebook
VP - Regulatory Affairs
John McGrath
  John McGrath LinkedIn Profile  John McGrath Twitter Account  John McGrath News  John McGrath on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/8/2017: Netwrix venture capital transaction
Next: 2/9/2017: Cinemood venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on tech company VC transactions. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary